Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (28)

« Back to Publications

Substantial international variation in the cost of blood group and save and crossmatch: A systematic review.

Fabiano G. et al, (2026), Br J Haematol

Defining Patient and Public Involvement and Engagement Tasks in Health Data Research: A Consensus Study.

Evans HG. et al, (2026), Health Expect, 29

Clinical decision support systems in transfusion.

Strickland LH. et al, (2026), Br J Haematol

Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A Systematic Review of the Evidence From the UK Perspective.

Farabi H. et al, (2025), EJHaem, 6

Unlocking the potential of electronic blood transfusion systems: Implementation insights from NHS hospitals in England.

Tomini F. et al, (2025), Br J Haematol, 207, 235 - 243

Development of a key performance indicator set for perioperative red blood cell transfusion.

Shah A. et al, (2025), BJA Open, 13

Understanding variations in the use of tranexamic acid in surgery: A qualitative interview study.

Strickland L. et al, (2025), Br J Haematol, 206, 965 - 976

Harnessing the potential of data-driven strategies to optimise transfusion practice.

Evans HG. et al, (2024), Br J Haematol, 204, 74 - 85

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.

Kaur G. et al, (2022), Nat Commun, 13

Identification of early neurodegenerative pathways in progressive multiple sclerosis.

Kaufmann M. et al, (2022), Nat Neurosci, 25, 944 - 955

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.

Kaufmann M. et al, (2021), Med, 2, 296 - 312.e8

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Faergeman SL. et al, (2020), Cell Death Dis, 11

Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.

Brencicova E. et al, (2017), PLoS One, 12

TNF Blockade Maintains an IL-10+ Phenotype in Human Effector CD4+ and CD8+ T Cells.

Roberts CA. et al, (2017), Front Immunol, 8

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.

Dendrou CA. et al, (2016), Sci Transl Med, 8

Load More